Profound Medical Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K is a current report filed by Profound Medical Corp. on February 12, 2026. The filing serves as a Regulation FD disclosure to announce the upcoming release of financial results for the fourth quarter and full year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding the timing of the financial report rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The only material event reported is the scheduling of the Q4 and full-year 2025 earnings release.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: Thursday, March 5, 2026, after market close.
- Conference Call: Scheduled for 4:30 p.m. Eastern Time on March 5, 2026, to review results and discuss business developments.
- Access: Details for the webcast and conference call are contained in the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the exact time of the earnings release on March 5, 2026, to ensure timely access to the data.
- Review Exhibit 99.1 (Press Release) for specific dial-in numbers and webcast links for the conference call.
- Monitor the company's investor relations website for the actual financial statements once released.